These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21493758)
1. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas. Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases. Chan ES; Pawel BR; Corao DA; Venneti S; Russo P; Santi M; Sullivan LM Pediatr Dev Pathol; 2013; 16(4):272-7. PubMed ID: 23530909 [TBL] [Abstract][Full Text] [Related]
3. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells. Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038 [TBL] [Abstract][Full Text] [Related]
4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Esheba GE; Pate LL; Longacre TA Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882 [TBL] [Abstract][Full Text] [Related]
5. Glypican 3: a novel marker in testicular germ cell tumors. Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513 [TBL] [Abstract][Full Text] [Related]
6. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Jin Z; Lahat G; Korchin B; Nguyen T; Zhu QS; Wang X; Lazar AJ; Trent J; Pollock RE; Lev D Clin Cancer Res; 2008 Aug; 14(16):5033-42. PubMed ID: 18698021 [TBL] [Abstract][Full Text] [Related]
7. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature. Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855 [TBL] [Abstract][Full Text] [Related]
8. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study. Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J; Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910 [TBL] [Abstract][Full Text] [Related]
9. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas. Franchi A; Massi D; Santucci M Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884 [TBL] [Abstract][Full Text] [Related]
11. Actin isoform pattern expression: a tool for the diagnosis and biological characterization of human rhabdomyosarcoma. Clément S; Orlandi A; Bocchi L; Pizzolato G; Foschini MP; Eusebi V; Gabbiani G Virchows Arch; 2003 Jan; 442(1):31-8. PubMed ID: 12536312 [TBL] [Abstract][Full Text] [Related]
12. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review. Fadare O Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
14. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409 [TBL] [Abstract][Full Text] [Related]
15. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry]. Harms D Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256 [TBL] [Abstract][Full Text] [Related]
17. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1. Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678 [TBL] [Abstract][Full Text] [Related]
18. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression and cluster analysis of mesenchymal and neural stem cell-associated proteins in pediatric soft tissue sarcomas. Sadikovic B; Graham C; Ho M; Zielenska M; Somers GR Pediatr Dev Pathol; 2011; 14(4):259-72. PubMed ID: 21162641 [TBL] [Abstract][Full Text] [Related]
20. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material. Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]